How an Epigenetic 'Lock' Drives a Rare Disease (1 of 1) (IMAGE)

American Association for the Advancement of Science (AAAS)

How an Epigenetic 'Lock' Drives a Rare Disease (1 of 1)

Caption

Culturing skin biopsies from systemic sclerosis patients with the drug JQ1 for 10 days cleared collagen in the samples. This material relates to a paper that appeared in the June 19, 2019, issue of Science Translational Medicine, published by AAAS. The paper, by J.Y. Shin at Johns Hopkins University School of Medicine in Baltimore, MD; and colleagues was titled, 'Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis.'

Credit

J.Y. Shin <i>et al., Science Translational Medicine</i> (2019)

Usage Restrictions

Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.